How big is the Australia Insulin Delivery Devices Market?

The Australia Insulin Delivery Devices Market size is expected to reach USD 705.52 million in 2024 and grow at a CAGR of 2.40% to reach USD 794.35 million by 2029. Read More

What is the current Australia Insulin Delivery Devices Market size?

In 2024, the Australia Insulin Delivery Devices Market size is expected to reach USD 705.52 million. Read More

Who are the key players in Australia Insulin Delivery Devices Market?

Insulet Corporation, Ypsomed, Novo Nordisk A/S, Medtronic and Eli Lilly and Company are the major companies operating in the Australia Insulin Delivery Devices Market. Read More

What years does this Australia Insulin Delivery Devices Market cover, and what was the market size in 2023?

In 2023, the Australia Insulin Delivery Devices Market size was estimated at USD 688.98 million. The report covers the Australia Insulin Delivery Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Australia Insulin Delivery Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Australia Insulin Delivery Devices Market Share

Statistics for the 2023 & 2024 Australia Insulin Delivery Devices market share, created by Mordor Intelligence™ Industry Reports. Australia Insulin Delivery Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Australia Insulin Delivery Devices Industry

The Australia Insulin Delivery Devices Market is consolidated, with few significant players. The major players such as Insulet Corporation, Ypsomed, and Novo Nordisk are working on innovations in insulin devices which is evident from the companies spending on research and developments to strengthen their market presence further.